A Startup Used AI to Make a Psychedelic Without the Trip

Mindstate Design Labs, a startup in Silicon Valley, has developed a novel psychoactive compound using artificial intelligence (AI). The company's CEO claims this compound is "the least psychedelic psychedelic that's psychoactive," suggesting it may produce the desired effects of psychedelics without the characteristic "trip" or altered state of consciousness. The startup, which has attracted funding from prominent investors, used AI to design and synthesize this new compound. The goal is to create a psychoactive substance that can provide therapeutic benefits, such as improved mood and cognition, without the disruptive and potentially risky experiences associated with traditional psychedelics. The article highlights the growing interest in developing alternative psychoactive compounds, particularly in the context of mental health treatment and cognitive enhancement. It also raises questions about the potential risks and regulatory challenges of these AI-driven pharmaceutical innovations.